Updates matching "Access to Health Care"

Governor Hochul has released her Executive Budget for the next fiscal year. ACS CAN is asking for increases in funding for the Cancer Services Program and tobacco control.

Today the Senate Health, Education, Labor and Pension (HELP) Committee voted to confirm Robert Califf as the next commissioner of the Food and Drug Administration (FDA).

LANSING, MI –As lawmakers dive into the 2022 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize improving access to cancer care and tobacco control funding, both of which will ease the burden of cancer in Michigan. “For nearly ten years, ACS CAN has

NASHVILLE, TN – “As lawmakers dive into the 2022 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation that will ease the burden of cancer on Tennesseans. “ACS CAN is asking the legislature to prioritize access to care for cancer patients

Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Leo Almeida COLUMBUS, OHIO – “As lawmakers dive into the 2022 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation that will ease the burden of cancer

The majority of cancer patients in the United States say they struggle to afford the costs of their cancer care.

COLUMBUS, OHIO – “Today, the Ohio legislature passed HB 122, which expands telehealth services in Ohio. On behalf of the 72,000 Ohioans who will be diagnosed with cancer this year, ACS CAN proudly supported HB 122. “The COVID-19 pandemic has placed more significant burdens on cancer patients and their

A new survey offers insight into how a national paid family and medical leave program could benefit cancer patients and survivors who struggle with missed work and lost income due to their illness.

The American Cancer Society Cancer Action Network (ACS CAN) released new survey data today examining some of the most common barriers providers face in performing recommended cancer biomarker testing.